# A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants

> **NCT07219589** · PHASE1 · RECRUITING · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 90 (estimated)

## Conditions studied

- Obesity
- Obese

## Interventions

- **DRUG:** HM17321
- **DRUG:** Placebo of HM17321

## Key facts

- **NCT ID:** NCT07219589
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-06
- **Primary completion:** 2027-03
- **Final completion:** 2027-03
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07219589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07219589, "A Single and Multiple Ascending Dose Study of HM17321 in Healthy and Obese Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07219589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*